advertisement
11.4 Prostaglandins (147)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins60577 Periocular skin hyperpigmentation in children treated with prostaglandin analogues
Al-Zobidi M
Journal of AAPOS 2015; 19: 49-53
60682 Influence of local application of glaucoma medications-travoprost eye drops on patients' tear film function
Zhang C
Pakistan journal of pharmaceutical sciences 2015; 28: 781-784
60335 Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results
Lee H
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 152-155
60425 Prostaglandin analogue-induced pigmentation of the skin of the nasal septum and nasal alae in a glaucoma patient
Holló G
European Journal of Ophthalmology 2015; 0: 0
60083 A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN
British Journal of Ophthalmology 2015; 99: 738-745
60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Rossi GC
Expert Opinion on Drug Safety 2015; 14: 619-623
60477 Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Kocabeyoglu S
Indian Journal of Ophthalmology 2015; 63: 15-19
60569 Effect of topical prostaglandin analogues on corneal hysteresis
Bolívar G
Acta Ophthalmologica 2015; 93: e495-e498
59909 The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Shin J
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 803-809
60558 Observations on Prostaglandin Orbitopathy
Custer PL
Ophthalmic Plastic and Reconstructive Surgery 2016; 32: 102-105
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304
60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Velpandian T
Current Eye Research 2015; 40: 561-571
60669 Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
Shimizu Y
Clinical Ophthalmology 2015; 9: 475-482
60134 Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
Park KH
BMC Ophthalmology 2014; 14: 160
60287 Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Tanna AP
Current Opinions in Ophthalmology 2015; 26: 116-120
60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Smedowski A
Journal of biochemical and pharmacological research 2014; 2: 175-184
60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kanamoto T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164
60168 Original preparations versus generics--latanoprost: how similar is different?
Leitritz MA
Ophthalmologe 2015; 112: 127-139
60508 Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma
Ussa F
Ophthalmology 2015; 122: 1040-8.e4
60251 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Natt NK
Indian Journal of Ophthalmology 2014; 62: 1136-1140
60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakata R
Journal of Glaucoma 2016; 25: e204-e208
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Rossetti L
BMC Ophthalmology 2015; 15: 7
60458 Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients
Pradhan ZS
Canadian Journal of Ophthalmology 2015; 50: 6-10
60630 Usability of prostaglandin monotherapy eye droppers
Drew T
British Journal of Ophthalmology 2015; 99: 1251-1254
60232 Prostaglandin-associated periorbitopathy in latanoprost users
Nakakura S
Clinical Ophthalmology 2015; 9: 51-56